BAA for COVID-19 Diagnostics, Vaccines and Therapeutics
As part of the government-wide effort to mitigate the spread of COVID-19 in U.S. communities, the U.S. Department of Health ...
Tag: Antivirals
Patients in Nebraska Part of First COVID-19 Clinical Trial in U.S.
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed ...
Columbia University Researchers Awarded $2 Million to Identify Antiviral Drugs for New Coronavirus
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential ...
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research ...
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses
The drug EIDD-1931 was effective against SARS and MERS viruses in the laboratory, and a modified version (EIDD-2801) could potentially ...
BARDA Seeks Input from Suppliers on Potential SARS-CoV-2 Medical Countermeasures
To support U.S. government medical countermeasure research and development in response to the COVID-19 outbreak, the Biomedical Advanced Research Development ...
Roche Donates Diagnostics, Medical Supplies for 2019-nCoV
Roche statement on 2019-nCoV (novel coronavirus) Basel, 31 January 2020 The World Health Organization (WHO) has declared a Public Health ...
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral
Atriva Therapeutics GmbH has announced the successful conclusion and top-line results of its Phase I clinical trial for its lead ...
AbCellera to Lead Development of Rapid Response Platform Against Pandemic Threats
AbCellera Biologics Inc. this week announced that it was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to ...
ZMapp Ebola Treatment to be Tested at Texas Biomed
Researchers at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers ...
Stopping Pandemic X: DARPA Names Researchers Working to Halt Outbreaks
The Defense Advanced Research Projects Agency (DARPA) launched the Pandemic Prevention Platform (P3) program in 2017, with the eventual goal of halting the spread ...
U.S. Seeks to Develop Late-Stage Smallpox Antivirals
The etiological agent responsible for smallpox disease, Variola viridae (VARV) is responsible for the deaths of hundreds of millions of ...
Happening This Week: ASM Biothreats
The American Society for Microbiology’s ASM Biothreats 2018 meeting is taking place February 12-14, 2018 in Baltimore, Maryland. ASM Biothreats ...
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
‘Lung Chip’ Project to Model Human Host Response to Influenza Virus Infection
The development of anti-influenza drugs has been limited by the fact that animal models do not accurately reflect the infection ...
Emergent Unveils Expanded CIADM Facility for Medical Countermeasure Preparedness
Emergent BioSolutions Inc. held a ribbon-cutting ceremony last week on May 10 to mark the formal opening of the company’s ...
BARDA Pre-Solicitations for Advancing Ebola Vaccines and Therapeutics
The Biomedical Advanced Research and Development Authority (BARDA) has issued two pre-solicitation notices supporting mid- and late-phase development of medical countermeasures ...
Monoclonal Antibody Cures Late-Stage Marburg Infection in Monkeys
A study led by scientists at the University of Texas Medical Branch Galveston National Laboratory and Mapp Biopharmaceutical has found ...
Medical Countermeasure Nonclinical Studies Network Contract Awards
The Nonclinical Studies Network is a key element in the successful development of U.S. medical countermeasures for biological threats, particularly ...
Study: Interferon Drug for Treatment of Ebola Virus Disease
A temporary lab was set up in a treatment center in Guinea, West Africa during the 2014-15 Ebola outbreak to ...
